Company to unveil TumorSight® Viz 1.4 and surgical outcome visualization capability, advancing precision and personalization in breast cancer surgery CHICAGO, IL – April 29, 2026 – SimBioSys®, an AI-driven precision medicine company revolutionizing how cancer is understood and treated, today…